MedTrace Logo

Impact of a Single Art Therapy Session on Mood and Symptom Burden in Palliative Care

NCT06924268 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this observational study is to explore whether a single art therapy session can improve mood and reduce symptom burden in adult palliative care patients at a Canadian inpatient unit. The main questions it aims to answer are:

* Does a single art therapy session reduce overall symptom burden, as measured by the Edmonton Symptom Assessment System (ESAS)?
* Does a single art therapy session improve mood, as measured by the Positive and Negative Affect Schedule (PANAS)?

Participants will:

* Complete two short questionnaires (ESAS and PANAS) before and after the session
* Participate in a 30-60 minute individual art therapy session

Conditions

Interventions

BEHAVIORAL

Single Art Therapy Session

Each participant will engage in a 30-60 minute structured art therapy session using pre-drawn coloring sheets featuring themes such as mandalas, nature scenes, and inspirational designs. A variety of coloring tools will be provided, including crayons, colored pencils, markers, gel pens, and watercolor paints. Sessions will be facilitated by the primary investigator, who will provide non-directive prompts and engage in casual conversation to foster comfort and engagement.

Sponsors & Collaborators

  • Dalhousie University

    collaborator OTHER

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Caitlin Lees, MA, MSc, MD, FRCPC · Nova Scotia Health Authority

  • Jonathan Clements, BSc · Dalhousie University

  • Lindsay Flinn, MD, CCFP (PC) · Nova Scotia Health Authority

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-08-01
Completion
2026-08-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06924268 on ClinicalTrials.gov